|Ask||25.99 x 100|
|Day's Range||21.32 - 21.66|
|52 Week Range||14.27 - 22.25|
|PE Ratio (TTM)||47.97|
|Dividend & Yield||0.39 (1.80%)|
|1y Target Est||N/A|
Hologic crushed Wall Street's fiscal second-quarter revenue and profit expectations late Wednesday, led by double-digit growth.
VIVUS Inc. (VVUS) reported a loss of 1 cent per share in the first quarter of 2017, which was narrower than a loss of 12 cents in the year-ago period as well as the Zacks Consensus Estimate of a loss of 13 cents
GlaxoSmithKline plc's (GSK) first quarter results came roughly in line with expectations. Glaxo reported first-quarter 2017 core earnings of 62 cents per American Depositary Share (ADS), in line with the Zacks Consensus Estimate.